Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1989
11/15/1989EP0341607A2 Anticoagulant peptide alcohols
11/15/1989EP0341603A2 Atrial peptide derivatives
11/15/1989EP0341602A2 Renin-inhibiting functionalized peptidyl aminodiols and - triols
11/15/1989EP0341558A2 Use and agent for diminishing the secondary effects of TNF
11/15/1989EP0341311A1 Hexapeptide and pharmaceutical preparation based thereon for curing erosive-ulcerous injuries to the digestive tract
11/15/1989EP0341304A1 Improved ricin molecules and ricin toxin conjugates
11/15/1989EP0341303A1 Monoclonal antibody against the rgd-directed adhesion receptor of endothelial cells
11/15/1989EP0341290A1 Immunoglobulin e competitor
11/15/1989EP0341273A1 Biological materials, processes for producing biological materials and for using such materials in therapy
11/15/1989EP0341264A1 Atriopeptins, guanylate cyclase activators, and phosphodiesterase inhibitors as treatment for glaucoma, hydrocephalus and cerebral edema (cranial fluid volume dysfunction)
11/15/1989EP0341252A1 Human polymorphic epithelial mucin polypeptides for use in therapy and diagnosis
11/15/1989CN1037155A 氨基酸衍生物 Amino acid derivatives
11/15/1989CN1037065A Preparation for activating hemocytes of bivalves for pearl production, and method for producing pearls using preparation
11/14/1989US4880921 Brain-specific drug delivery
11/14/1989US4880915 Tumor necrosis factor; dye ligand covalently bound to crosslinked agarose
11/14/1989US4880913 Precipitation, adsorption
11/14/1989US4880829 Analgesics, hypotensive agents
11/14/1989US4880819 4-aminopyridine derivatives for improving impaired brain function
11/14/1989US4880816 Brain-specific delivery of dopamine utilizing dihydropyridine/pyridinium salt-type redox carriers
11/14/1989US4880812 Antitumor agents
11/14/1989US4880780 Respiratory system disorders
11/14/1989US4880779 Method of prevention or treatment of AIDS by inhibition of human immunodeficiency virus
11/14/1989US4880778 Combinations having synergistic growth hormone releasing activity and methods for use thereof
11/14/1989US4880777 Synthetic peptides having growth hormone releasing activity
11/14/1989US4880776 Blocking and unblocking a catalytic site
11/14/1989US4880742 Prostaglandin biosynthesis inhibitors
11/14/1989US4880626 Immunology, vaccines
11/14/1989EP0271521A4 Lipopolysaccharide and natural factor compositions for anti-tumor therapy and method of treatment.
11/14/1989CA1263000A1 Derivatives of 2-azabicyclo[3.1.0]hexane-3- carboxylic acid, a process for their preparation, agents containing them and their use; and 2- azabicyclo[3.1.0]hexane derivatives as intermediates, and a process for their preparation
11/14/1989CA1262862A1 Tetrapyrrole therapeutic agents
11/09/1989DE3815886A1 Polypeptides, their preparation and use
11/08/1989EP0341103A1 Method for stabilizing solutions of human albumin, and solution so obtained
11/08/1989EP0341100A2 DNA coding for thymosin and TNF
11/08/1989EP0341006A2 Smooth muscle cell growth inhibitor
11/08/1989EP0340933A2 Heparin-containing formulations
11/08/1989EP0340837A1 Recombinant GAG precursor of HIV, product, process, and use as aids vaccine
11/08/1989EP0340741A2 Polyethylene glycol derivatives, modified peptides and production thereof
11/08/1989EP0340604A2 Monoclonal antibody and its use
11/08/1989EP0340573A2 Proteins, their production and their use
11/08/1989EP0340333A2 Novel physiologically active polypeptide and pharmaceutical composition
11/08/1989CN1036987A Human c3b/c4b receptor (cr1)
11/07/1989US4879403 Process for the preparation of cis, endo-2-azabicyclo-[3.3.0]-octane-3-carboxylic acids
11/07/1989US4879374 Genetic vectors, genetic engineering
11/07/1989US4879313 Novel platelet-aggregation inhibitors
11/07/1989US4879285 Fertility control
11/07/1989US4879278 Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
11/07/1989US4879273 Glucogenesis control, antidiabetic
11/07/1989US4879272 On walls of container
11/07/1989US4879227 Gene expression of protein
11/07/1989US4879226 Novel human physiologically active polypeptide
11/07/1989US4879224 DNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor polypeptides
11/07/1989US4879111 Treatment of infections with lymphokines
11/07/1989US4879110 Antihypertensive hyperimmune milk, production, composition, and use
11/07/1989US4879109 Method for treating burns
11/07/1989EP0298990A4 Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive.
11/07/1989EP0246322A4 Treatment of aids-type disease.
11/07/1989CA1262696A1 Process for the microbiological preparation of the human serum-albumin
11/07/1989CA1262695A1 Process for the microbiological preparation of the human serum-albumin
11/07/1989CA1262694A1 Method of improving the yield of heterologous protein produced by cultivating recombinant bacteria
11/07/1989CA1262682A1 Treatment of biological and pharmaceutical products adsorbed on a solid phase with virus and pyrogen inactivating agents
11/02/1989WO1989010416A1 PROTECTIVE PEPTIDES DERIVED FROM HUMAN IMMUNODEFICIENCY VIRUS-1 gp160
11/02/1989WO1989010412A1 Detection of neu gene expression and products
11/02/1989WO1989010409A1 Bone and cartilage inductive compositions
11/02/1989WO1989010407A1 Homogeneous dimeric m-csf and storage stable formulations thereof
11/02/1989WO1989010403A1 Human gm-csf variants
11/02/1989WO1989010402A1 Low molecular weight derivatives of prourokinase and pharmaceutical compositions containing the same
11/02/1989WO1989010374A1 Aprotinin analogues and a process for the production thereof
11/02/1989WO1989010348A1 Fatty amino acids, and homo- and hetero-oligomers and conjugates thereof
11/02/1989WO1989010158A1 Improved radiotherapy
11/02/1989WO1989010140A1 Further improvements relating to drug delivery systems
11/02/1989WO1989010139A1 Preparation with antibody activity and broad spectrum
11/02/1989WO1989010136A1 Prophylactic and therapeutic methods for treating edema with phallotoxins
11/02/1989WO1989010135A1 Hybrid peptides and methods of their use
11/02/1989WO1989010134A1 Chimeric peptides for neuropeptide delivery through the blood-brain barrier
11/02/1989WO1989010133A1 Stem cell inhibitors
11/02/1989WO1989010098A1 Stimulation of chemotaxis by chemotactic peptides
11/02/1989EP0340109A2 Anti-T-cell receptor determinants as autoimmune disease treatment
11/02/1989EP0340056A1 Process for purification of peptides
11/02/1989EP0340005A2 Use of cytokines for improvement of radiotherapy
11/02/1989EP0340002A1 A human-human hybridoma derived monoclonal antibody, and the use thereof
11/02/1989EP0339942A2 Aprotinin analogues and process for the production thereof
11/02/1989EP0339919A2 Method for purifying antithrombin-III and antithrombin-III preparation containing said antithrombin-III
11/02/1989EP0339905A2 Wound healing compositions containing growth factors and retinoids
11/02/1989EP0339656A2 Undenatured whey protein concentrate
11/02/1989EP0339549A2 Tyr-peptide analogs
11/02/1989EP0339505A2 Monoclonal antibodies to tissue plasminogen activator (t-PA) which prolong its functional half-life
11/02/1989EP0339504A2 Human immunodeficiency virus (HIV) env-coded peptide capable of eliciting HIV-inhibiting antibodies in mammals
11/02/1989EP0339483A2 Renin inhbiting amino-acid derivatives
11/02/1989EP0339285A2 Recombinant endonexin II
11/02/1989EP0339193A1 Peptide ligands for bombesin receptors
11/02/1989EP0339163A2 Monoclonal antibodies specific for HIV and hybridomas for their production
11/01/1989CN1036795A 肽衍生物 Peptide derivatives
11/01/1989CN1036793A Monoclonal antibody specific to mucin-like glycoprotein surface antigen on human carcinoma cells
10/1989
10/31/1989US4877866 Method of producing a virus safe, storage-stable, and intravenously tolerable immunoglobulin-G preparation
10/31/1989US4877864 Osteoinductive factors
10/31/1989US4877770 Glycyl-histidyl-lysine: copper wound healing agents
10/31/1989US4877729 Blood cell growth stimulants
10/31/1989US4877615 Antifungal product
10/31/1989US4877614 Biologically active fragments of human antihemophilic factor and method for preparation thereof
10/31/1989US4877610 Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms
1 ... 3049 3050 3051 3052 3053 3054 3055 3056 3057 3058 3059 3060 3061 3062 3063 3064 3065 3066 3067 3068 3069 ... 3163